Marc-André Kasper, VP Chemistry, will hold a workshop with the title “Examining the Importance of Linker Stability” and give a talk titled “Conjugation Technology-Enabled Solutions Broaden the Scope of Conjugatable Drugs”.
Olivier Marcq, VP CMC, will talk about “Analyzing the Impact of Linker-Payload Technologies on Early-Phase Development”.
Learn more about the ADC Linker & Conjunction Summit on the conference website.
